Axess Shows Promise for Living HD Grafts

A synthetic, biocompatible blood vessel becomes colonized by a patient's own tissue. Now tested in 11 patients for more than 600 treatments, the new graft material is safe and works well—with no aneurysms or infections to date.

Read the full article » | Posted 05-12-2022

Related Articles

• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
• FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
• Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
• Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026